HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
KIR2DS1 |
Q14954
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1
|
Receptor
|
|
0.537 |
0.769 |
PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
IGKV3-20 |
P01619
|
immunoglobulin kappa variable 3-20
|
Immune response
|
|
0.736 |
0.308 |
MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
MIR17 |
|
microRNA 17
|
|
|
0.459 |
0.846 |
MIR223 |
|
microRNA 223
|
|
|
0.433 |
0.808 |
MIR17HG |
Q75NE6
|
miR-17-92a-1 cluster host gene
|
|
|
0.483 |
0.808 |
LINC02605 |
|
long intergenic non-protein coding RNA 2605
|
|
|
0.490 |
0.769 |
ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
ABCG2 |
Q9UNQ0
|
ATP binding cassette subfamily G member 2 (Junior blood group)
|
Transporter
|
2.1E-32 |
0.419 |
0.885 |
KIR3DL1 |
P43629
|
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1
|
Receptor
|
8.4E-14 |
0.475 |
0.769 |
HLA-G |
P17693
|
major histocompatibility complex, class I, G
|
|
1.4E-11 |
0.461 |
0.769 |
KRT20 |
P35900
|
keratin 20
|
|
9.1E-11 |
0.388 |
0.846 |
MTHFR |
P42898
|
methylenetetrahydrofolate reductase
|
|
3.2E-10 |
0.337 |
0.885 |
ARHGAP24 |
Q8N264
|
Rho GTPase activating protein 24
|
|
3.9E-10 |
0.456 |
0.808 |
TCL1A |
P56279
|
T cell leukemia/lymphoma 1A
|
|
5.7E-10 |
0.558 |
0.500 |
SOAT1 |
P35610
|
sterol O-acyltransferase 1
|
Enzyme
|
7.4E-10 |
0.424 |
0.846 |
RTEL1 |
Q9NZ71
|
regulator of telomere elongation helicase 1
|
Enzyme
|
8.9E-10 |
0.459 |
0.808 |
ANPEP |
P15144
|
alanyl aminopeptidase, membrane
|
Enzyme
|
3.7E-09 |
0.462 |
0.769 |
GEM |
P55040
|
GTP binding protein overexpressed in skeletal muscle
|
|
1.2E-08 |
0.467 |
0.769 |
PLAAT4 |
Q9UL19
|
phospholipase A and acyltransferase 4
|
|
1.2E-07 |
0.500 |
0.808 |
PRAME |
P78395
|
preferentially expressed antigen in melanoma
|
|
2.4E-07 |
0.531 |
0.577 |